TUCSON, AZ / ACCESS Newswire / February 19, 2026 / Umbrella Labs today announced expanded research procurement availability of tesamorelin in lyophilized vial format to support laboratories building ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window MELBOURNE, ...

According to Theratechnologies, Egrifta WR is set to replace Egrifta SV. The Food and Drug Administration (FDA) has approved Egrifta WR ™, a new concentrated formulation (F8) of tesamorelin, for the ...

MONTREAL, March 20, 2021 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and commercialization of ...

Tesamorelin, a synthetic peptide analog of growth hormone-releasing hormone (GHRH), has recently garnered attention for its unique biochemical properties and intriguing impact on various physiological ...

November 12, 2010 — The US Food and Drug Administration (FDA) has approved tesamorelin acetate injection (Egrifta; Theratechnologies, Inc, and marketed by EMD Serono) as the first and only treatment ...

Presentation at Conference on Retroviruses and Opportunistic Infections (CROI) demonstrates association between excess visceral abdominal fat (EVAF) reduction and decreased prevalence of metabolic ...

Please provide your email address to receive an email when new articles are posted on . “We have phenomenally successfully direct-acting antiretrovirals for HIV that have saved the lives of people and ...

Review the side-effects of Tesamorelin as documented in medical literature. The term "side effects" refers to unintended effects that can occur as a result of taking the medication. In majority of the ...

MONTREAL, July 07, 2020 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) (NASDAQ: THTX), a commercial-stage biopharmaceutical company, is pleased to announce that it has ...